swisspartners’s Bristol-Myers Squibb BMY Stock Holding History

swisspartners’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-33,500	Closed	-$2.45M	–	81
2022 Q1	$2.45M	Hold	33,500	–	–	1.94%	14
2021 Q4	$2.12M	Buy	33,500 +9,000	+37%	+$528K	1.5%	16
2021 Q3	$1.45M	Sell	24,500 -6,000	-20%	-$395K	1.12%	27
2021 Q2	$2.04M	Hold	30,500	–	–	1.45%	18
2021 Q1	$1.93M	Buy	30,500 +24,500	+408%	+$1.52M	1.57%	18
2020 Q4	$366K	Buy	+6,000	New	+$369K	0.32%	59

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

swisspartners's BMY Position: Q2 2022 in Review

swisspartners sold out of Bristol-Myers Squibb (BMY) in Q2 2022, closing a stake of 33,500 shares — an estimated $2.45M sold.

swisspartners first reported a position in BMY in Q4 2020 and held it in 6 quarters. The position peaked at $2.45M in Q1 2022. 2,537 funds tracked by Wall St. Rank hold BMY as of Q2 2022.

swisspartners reported no remaining Bristol-Myers Squibb position as of Q2 2022 after selling out during the quarter.
swisspartners sold 33,500 Bristol-Myers Squibb shares in Q2 2022, an estimated $2.45M.
swisspartners first reported a position in Bristol-Myers Squibb in Q4 2020 and held it in 6 quarters.
swisspartners's Bristol-Myers Squibb position peaked at $2.45M in Q1 2022.
2,537 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2022.

Based on swisspartners's 13F filing for Q2 2022, filed 10 Aug 2022.